Drug derived from red wine may combat obesity, study says

11/5/2008 | BBC

Sirtris Pharmaceuticals' drug candidate SRT1720 partially prevented weight gain in mice on a high-fat diet when given at low dosage, and it completely prevented weight gain when given in high doses over 10 weeks, French researchers reported. The treatment, which is derived from the red-wine extract resveratrol, also raised blood-sugar tolerance and insulin sensitivity, according to the study.

View Full Article in:

BBC

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC